BrainStorm Announces Treatment of Final Patient in US Multicenter Double Blinded Phase 2 ALS Trial; Nektar Submits Investigational New Drug Application (IND) for NKTR-214 Print E-mail
By Marilyn Mullen   
Wednesday, 07 October 2015 18:43
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 7, 2015.    
Read more...
 
Catalyst Pharma Announces a Clinical Trial for Pediatric Patients; AcelRx Announces Initiation of Clinical Study with ARX-04 Print E-mail
By William Kent   
Tuesday, 06 October 2015 19:17
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 6, 2015. 
Read more...
 
Baxalta and Momenta Announce Initiation of Pivotal Clinical Trial for M923; Boston Scientific Receives FDA Approval For SYNERGY™ Print E-mail
By David Fowler   
Monday, 05 October 2015 18:58
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 5, 2015. 
Read more...
 
Anthera Announces Initiation of the SOLUTION Clinical Study of Oral Sollpura(R) (liprotamase); FDA Accepts Novartis/Sandoz Regulatory Submission for Proposed Biosimilar to Enbrel Print E-mail
By Josh Gee   
Friday, 02 October 2015 18:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 2, 2015.  
Read more...
 
Research From the Mayo Clinic Utilizing the BVA-100 Blood Volume Analyzer; CEL-SCI Reports September Patient Enrollment for Its Phase 3; XOMA Announces Development and Commercialization Agreement Print E-mail
By Marilyn Mullen   
Thursday, 01 October 2015 18:41
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 1, 2015.   
Read more...
 
Novartis Announces NEJM Publication Of Secukinumab Phase III Data; Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study; Jazz Pharma Announces FDA Acceptance for Filing for Defibrotide Print E-mail
By Josh Gee   
Wednesday, 30 September 2015 19:52
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 30, 2015.   
Read more...
 
First Human Patient Treated in Phase 1b Study of Advaxis's ADXS-HER2; RXi Pharma Granted Patent in China for Lead Clinical Candidate RXI-109 Print E-mail
By David Fowler   
Monday, 28 September 2015 19:19
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 28, 2015.   
Read more...
 
Galapagos to Advance Filgotinib to Phase 3 in Rheumatoid Arthritis; Celgene's VIDAZA Receives Positive CHMP Opinion Print E-mail
By Josh Gee   
Friday, 25 September 2015 18:38
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 25, 2015.
Read more...
 
Celator Announces Positive Results from R&D Programs; Keryx Receives European Approval for Fexericx Print E-mail
By Marilyn Mullen   
Thursday, 24 September 2015 19:36
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 24, 2015.
Read more...
 
Conatus Announces Top-line Results From Multicenter Phase 2 Portal Hypertension Trial; Pulmatrix to Report Clinical Data on PUR0200 Print E-mail
By Josh Gee   
Wednesday, 23 September 2015 18:37
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 23, 2015.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 3 of 369

Newsletter